Meningioma Treatment: Hospitals, Costs, and Global Care

What is Meningioma Treatment?

Meningioma treatment focuses on removing or controlling tumours that grow in the membranes (meninges) covering the brain and spinal cord. Most meningiomas are benign (non-cancerous), but some can be malignant (cancerous) or recur after treatment.

The goal of treatment is to relieve pressure on the brain or spinal cord, reduce symptoms, and prevent further growth. Common treatment options include:

• ‍Surgery - removing the tumour fully or partially, depending on its location.‍
• Radiation therapy - targeting remaining tumour cells when complete removal is not possible.‍
• Stereotactic radiosurgery (SRS) - a focused, high-dose radiation method for small or difficult-to-reach tumours.‍
• Observation (watchful waiting) - monitoring slow-growing tumours with regular scans.‍
• Medications - in rare cases, drugs may be used if the tumour is aggressive or recurrent.

A common myth is that meningiomas always cause symptoms. In reality, many are discovered incidentally during scans for other reasons and may not need immediate treatment.

Doctors decide on the treatment plan based on:

• Tumour size and location
• Growth rate (benign vs malignant)
• Patient’s age and overall health
• Symptoms affecting daily life

With proper treatment, many patients lead healthy and active lives.

Why Do People Need Meningioma Treatment?

Meningioma treatment is necessary because these tumours, though often benign, can still grow and press on the brain or spinal cord. This pressure may cause headaches, seizures, or problems with vision, memory, or movement. In some cases, meningiomas may recur or show aggressive behaviour. Treatment helps relieve symptoms, protect vital brain functions, and prevent further complications.

Causes of Meningiomas

The exact reason why meningiomas develop is not always known, but certain factors raise the risk:

• ‍Genetic mutations - changes in tumour-suppressor genes such as NF2.‍
• Radiation exposure - previous radiation to the head, especially at a young age.‍
• Hormonal influence - higher occurrence in women suggests a link with oestrogen and progesterone.‍
• Age - most cases occur after the age of 40.‍
• Family history - inherited conditions like neurofibromatosis type 2.

Symptoms of Meningiomas

Meningioma symptoms depend on tumour size and location. Common ones include:

• ‍Headaches - often persistent and increasing in intensity.‍
• Seizures - new seizures in adults may indicate a brain tumour.‍
• Vision changes - blurred vision, double vision, or vision loss.‍
• Hearing issues - ringing in the ears or hearing loss.‍
• Weakness or numbness - affecting arms or legs.‍
• Cognitive or personality changes - memory loss, confusion, or mood shifts.
  

When These Symptoms Lead to Treatment

Doctors recommend starting treatment when:

• A meningioma is confirmed through scans or biopsy.
• Symptoms worsen and interfere with daily life.
• The tumour shows fast growth or aggressive features.
• Vital brain or spinal cord functions are at risk.

Getting diagnosed early and receiving the right treatment significantly improves patient outcomes. Myheco helps patients connect with leading hospitals worldwide for timely and effective meningioma care.

Success Rate & Outcomes of Meningioma Treatment

Understanding Success Rate

Meningiomas are usually slow-growing, and most are grade 1 or grade 2 (benign). Rarely, they appear as grade 3 (aggressive) and behave more malignantly.

According to Cancer Research UK:

• ‍Early-stage (grade 1-2): Almost 70% of patients survive for 10 years or more. With surgery or radiosurgery, many can return to normal life.‍
• Aggressive (grade 3): Around 40% of patients survive for 10 years or more. These require surgery plus radiation and carry higher risks of recurrence.

These figures show why early detection and treatment are critical in improving long-term survival and quality of life.

What Does ‘Success’ Mean?

Success in meningioma treatment does not always mean cure. It may involve:

• Complete or partial tumour removal.
• Preventing tumour regrowth.
• Relieving symptoms such as headaches or seizures.
• Preserving memory, vision, and movement.
• Improving overall quality of life.

Approach of Leading Hospitals

Leading hospitals use a multidisciplinary and patient-focused approach that includes:

• ‍Advanced imaging (MRI, PET-CT, functional scans) for accurate planning.‍
• Microsurgical and minimally invasive techniques to reduce complications.‍
• Radiosurgery and proton therapy for tumours near delicate brain structures.‍
• Multidisciplinary boards where neurosurgeons, oncologists, and radiologists collaborate.‍
• Rehabilitation and long-term follow-up to support recovery and prevent relapse.

This combination of modern technology, experienced specialists, and holistic care ensures better survival rates, improved recovery, and enhanced quality of life for meningioma patients.

Expert Insights

Dr. Amitava Ray, Senior Neurosurgeon at Apollo Hospitals, Hyderabad, explains that around half of all brain tumours are benign, often arising from the coverings of the brain and called meningiomas. These tumours are surgically removable, and once removed, most patients return to normal lives with normal life expectancy.

He notes that only a very small proportion of meningiomas may turn malignant, but in the vast majority of cases, surgery offers an excellent outcome with minimal long-term impact.

How myheco Supports International Patients  

Myheco ensures that international patients receive complete support—from connecting with experienced neurosurgeons and neuro-oncology specialists to managing every aspect of their treatment journey. With transparent guidance, expert coordination, and trusted hospital partnerships, myheco helps patients access advanced meningioma treatment safely and efficiently.

Medical Guidance for Meningioma Treatment  

• Connects international patients with expert neurosurgeons and neuro-oncology specialists experienced in brain and spine tumours
• Arranges online or video consultations before travel to confirm diagnosis and plan surgery, radiosurgery, or radiation therapy
• Provides second medical opinions to help patients choose the most appropriate treatment approach, including advanced options such as proton therapy

Travel Assistance for Meningioma Care  

• Issues medical visa invitation letters from accredited hospitals
• Guides patients and families through the visa application process
• Assists with flight bookings aligned with treatment schedules
• Offers complimentary airport pickup and ensures smooth transfers

Cost Transparency and Patient Support  

• Provides detailed cost estimates for surgery, radiosurgery, radiation therapy, and proton therapy
• Ensures transparent pricing with no hidden charges
• Offers multilingual patient coordinators for seamless communication
• Supports patients throughout their journey—from medical report review to post-treatment follow-up care
• Has supported numerous international patients in accessing advanced neurosurgical treatment safely and efficiently

Choosing myheco means expert care, faster access, and comprehensive support throughout your treatment journey.

Note: Myheco does not provide medical advice.

Patient Stories

Kenyan Patient Treated for Recurrent Meningioma at Max Hospital, Delhi

Scholasticah Ogato, a patient from Kenya, was first diagnosed with a brain tumour in 2016. Despite undergoing surgery in Nairobi, the tumour recurred as a recurrent meningioma affecting her eye and temporal bone. In 2018, she travelled to Max Super Speciality Hospital, Saket, where she received stereotactic radiation therapy under Dr. Dodul Mondal. The precision treatment helped relieve her severe headaches and pain, and she now continues to recover with hope of regaining her vision. She describes Max Hospital as “a home away from home” for international patients.

Nigerian Patient Recovers After Meningioma Surgery at Max Hospital, Gurugram

Mr. Nnodim Chigozie from Nigeria was left immobile due to a large meningioma, compounded by obesity. After struggling in his home country, he consulted Dr. Arun Saroha, Director of Neurosciences at Max Hospital, Gurugram. He underwent a total excision surgery, which was carried out successfully despite the complexity of his case. Within a few days, he was walking again, eating normally, and discharged in under two weeks. He expressed gratitude for the care, expertise, and supportive environment provided by Max Healthcare.

Step-by-Step: Your Journey to Treatment Across the Globe

✅ Share your medical reports
✅ Receive personalised treatment plans from leading hospitals
✅ Choose the option that suits you best
✅ Let us handle the arrangements